TABLE 1.
Demographic and clinical characteristics of donor and recipient by type of organ transplant.
| Kidney | Liver | Heart | Lung | |||||
|---|---|---|---|---|---|---|---|---|
| 4,029 | 2,219 | 434 | 215 | |||||
| N | % | N | % | N | % | N | % | |
| Sex (recipient) | ||||||||
| M | 2,599 | 64.5% | 1717 | 77.4% | 306 | 70.5% | 143 | 66.5% |
| F | 1,430 | 35.5% | 502 | 22.6% | 128 | 29.5% | 72 | 33.5% |
| Age (recipient) | ||||||||
| <18 years | 110 | 2.7% | 107 | 4.8% | 69 | 15.9% | 10 | 4.7% |
| 18–64 years | 3,112 | 77.2% | 1828 | 82.4% | 336 | 77.4% | 194 | 90.2% |
| 65 + years | 807 | 20.0% | 284 | 12.8% | 29 | 6.7% | 11 | 5.1% |
| Mean (SD) years | 52.1 (14.3) | 52.7 (14.0) | 43.7 (19.1) | 44.7 (15.6) | ||||
| BMI (recipient) | ||||||||
| Underweight | 264 | 6.6% | 124 | 5.7% | 67 | 15.7% | 33 | 18.2% |
| Normal | 2,155 | 53.5% | 923 | 42.4% | 229 | 53.5% | 91 | 50.3% |
| Overweight | 1,250 | 31.0% | 824 | 37.9% | 103 | 24.1% | 43 | 23.8% |
| Obese | 357 | 8.9% | 305 | 14.0% | 29 | 6.8% | 14 | 7.7% |
| Missing | 3 | 43 | 6 | 34 | ||||
| Transplant hospital stay length | ||||||||
| Mean (SD) days | 17.3 (10.3) | 24.7 (20.1) | 44.1 (31.9) | 35.9 (21.9) | ||||
| Donor | ||||||||
| Living | 421 | 10.4% | 18∗ | 0.8% | 0 | 0.0% | 0 | 0.0% |
| Dead | 3,608 | 89.6% | 2,201 | 99.2% | 434 | 100.0% | 215 | 100.0% |
| Cause of death (donor) | ||||||||
| Cerebral hemorrhage | 1997 | 55.3% | 1,254 | 57.0% | 165 | 38.0% | 103 | 47.9% |
| Post-anoxic encephalopathy | 416 | 11.5% | 237 | 10.8% | 45 | 10.4% | 14 | 6.5% |
| Ischemic stroke | 307 | 8.5% | 181 | 8.2% | 16 | 3.7% | 11 | 5.1% |
| Other | 888 | 24.6% | 529 | 24.0% | 208 | 47.9% | 87 | 40.5% |
| Sex (donor) | ||||||||
| M | 2,157 | 53.5% | 1,243 | 56,0% | 276 | 63.6% | 122 | 56.7% |
| F | 1,872 | 46.5% | 976 | 44,0% | 158 | 36.4% | 93 | 43.3% |
| Age (donor) | ||||||||
| <18 years | 128 | 3.2% | 79 | 3.6% | 70 | 16.1% | 24 | 11.2% |
| 18–64 years | 2,490 | 61.8% | 1,169 | 52.7% | 351 | 80.9% | 183 | 85.1% |
| 65 + years | 1,411 | 35.0% | 971 | 43.8% | 13 | 3.0% | 8 | 3.7% |
| Mean (SD) years | 55.8 (17.1) | 57.9 (18.7) | 36.1 (17.3) | 40.8 (15.8) | ||||
| BMI (donor) | ||||||||
| Underweight | 108 | 2.7% | 62 | 2.8% | 37 | 8.5% | 9 | 4.2% |
| Normal | 1806 | 45.0% | 943 | 42.9% | 211 | 48.6% | 139 | 64.7% |
| Overweight | 1,516 | 37.8% | 890 | 40.5% | 143 | 32.9% | 49 | 22.8% |
| Obese | 584 | 14.5% | 301 | 13.7% | 43 | 9.9% | 18 | 8.4% |
| Missing | 15 | 23 | 0 | 0 | ||||
| Infections (donor)∗ | 616 | 17.1% | 291 | 14.9% | 50 | 11.5% | 14 | 6.5% |
| Neoplasm/neoplasia (donor)∗ | 126 | 3.5% | 114 | 5.2% | 8 | 1.9% | 7 | 3.3% |
| Indications for transplant | ||||||||
| Glomerular nephropathies | 1719 | 42.7% | ||||||
| Cystic nephropathies | 803 | 19.9% | ||||||
| Hypertensive nephrosclerosis | 347 | 8.6% | ||||||
| Tubular and interstitial nephropathies | 273 | 6.8% | ||||||
| Diabetic nephropathy | 222 | 5.5% | ||||||
| Cirrhosis | 1,251 | 56.4% | ||||||
| Malignant neoplasms | 707 | 31.9% | ||||||
| Cardiomyopathies | 257 | 59.2% | ||||||
| Coronary artery disease | 110 | 25.3% | ||||||
| Cardiopathies | 41 | 9.4% | ||||||
| Cystic fibrosis | 80 | 37.2% | ||||||
| Idiopathic pulmonary fibrosis | 53 | 24.7% | ||||||
| Emphysema/COPD° | 32 | 14.9% | ||||||
| Other | 665 | 16.5% | 261 | 11.8% | 26 | 6.0% | 50 | 23.3% |
| Charlson index | ||||||||
| 0–1 | 3,280 | 81.4% | 762 | 34.3% | 226 | 52.1% | 186 | 86.5% |
| 2 | 612 | 15.2% | 1,048 | 47.2% | 136 | 31.3% | 24 | 11.2% |
| 3+ | 137 | 3.4% | 409 | 18.4% | 72 | 16.6% | 5 | 2.3% |
| Comorbidities and comedications | ||||||||
| Cancer | 258 | 6.4% | 72 | 3.2% | 24 | 5.5% | 20 | 9.3% |
| Diabetes | 533 | 13.2% | 642 | 28.9% | 57 | 13.1% | 55 | 25.6% |
| Thyroid disease | 521 | 12.9% | 119 | 5.4% | 83 | 19.1% | 8 | 3.7% |
| Lipid metabolism disorders | 235 | 5.8% | 82 | 3.7% | 43 | 9.9% | 11 | 5.1% |
| Hypertension | 2,860 | 71.0% | 440 | 19.8% | 109 | 25.1% | 35 | 16.3% |
| Depression | 201 | 5.0% | 125 | 5.6% | 36 | 8.3% | 29 | 13.5% |
| Infections | 163 | 4.0% | 162 | 7.3% | 18 | 4.1% | 9 | 4.2% |
| Anticoagulants | 434 | 10.8% | 275 | 12.4% | 206 | 47.5% | 31 | 14.4% |
| Antiplatelet | 1,354 | 33.6% | 92 | 4.1% | 155 | 35.7% | 24 | 11.2% |
| Statins | 1,581 | 39.2% | 259 | 11.7% | 130 | 30.0% | 23 | 10.7% |